AAAAAA

   
Results: 1-6 |
Results: 6
The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type1
Authors: Tian, XR Hsin, LW Webster, EL Contoreggi, C Chrousos, GP Gold, PW Habib, K Ayala, A Eckelman, WC Jacobson, AE Rice, KC
Citation: Xr. Tian et al., The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type1, BIOORG MED, 11(3), 2001, pp. 331-333
Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor
Authors: Hsin, LW Webster, EL Chrousos, GP Gold, PW Eckelman, WC Contoreggi, C Rice, KC
Citation: Lw. Hsin et al., Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor, BIOORG MED, 10(8), 2000, pp. 707-710
Synthesis of [H-3] (4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: A potent radioligand for corticotropin-releasing hormone type 1 receptor
Authors: Hsin, LW Webster, EL Chrousos, GP Gold, PW Eckelman, WC Contoreggi, C Rice, KC
Citation: Lw. Hsin et al., Synthesis of [H-3] (4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: A potent radioligand for corticotropin-releasing hormone type 1 receptor, J LABEL C R, 43(9), 2000, pp. 899-908
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates (vol 97, pg 6079, 2000)
Authors: Habib, KE Weld, KP Rice, KC Pushkas, J Champoux, M Listwak, S Webster, EL Atkinson, AJ Schulkin, J Contoreggi, C Chrousos, GP McCann, SM Suomi, SJ Higley, JD Gold, PW
Citation: Ke. Habib et al., Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates (vol 97, pg 6079, 2000), P NAS US, 97(15), 2000, pp. 8745-8745
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
Authors: Habib, KE Weld, KP Rice, KC Pushkas, J Champoux, M Listwak, S Webster, EL Atkinson, AJ Schulkin, J Contoreggi, C Chrousos, GP McCann, SM Suomi, SJ Higley, JD Gold, PW
Citation: Ke. Habib et al., Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates, P NAS US, 97(11), 2000, pp. 6079-6084
Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress
Authors: Wong, ML Webster, EL Spokes, H Phu, P Ehrhart-Bornstein, M Bornstein, S Park, CS Rice, KC Chrousos, GP Licinio, J Gold, PW
Citation: Ml. Wong et al., Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress, LIFE SCI, 65(4), 1999, pp. PL53-PL58
Risultati: 1-6 |